A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome

Clinical trial NCT07285005 · RECRUITING

Trial details

NCT number: NCT07285005
Sponsor: Kaken Pharmaceutical
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Venous Malformations Lymphatic Malformations Klippel-Trenaunay Syndrome CLOVES Syndrome

Start date: 2026-05-13
Primary completion: 2028-02-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.